Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=17121877&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 500 Internal Server Error
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Of spiders and crabs: the emergence of lysophospholipids and their metabolic pathways as targets for therapy in cancer Murph M; Tanaka T; Liu S; Mills GBClin Cancer Res 2006[Nov]; 12 (22): 6598-602Lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P), two small lysophospholipids, are potent inducers of many of the hallmarks of cancer including cell proliferation, survival, migration, invasion, and neovascularization in in vitro and in vivo tumor models. Furthermore, the enzymes metabolizing LPA and S1P and their receptors are aberrant in multiple cancer lineages and exhibit transforming activity altering patterns and targets for metastasis. Several recent studies show the remarkable activity of new chemical genomics and/or potential novel drugs in preclinical models. Combined with the physiologic and pathophysiologic activities of LPA and S1P, these studies suggest the implementation of preclinical and clinical evaluation of LPA and S1P as therapeutic targets.|*Drug Delivery Systems[MESH]|Animals[MESH]|Humans[MESH]|Lysophospholipids/antagonists & inhibitors/isolation & purification/*metabolism/*physiology[MESH]|Metabolic Networks and Pathways[MESH]|Models, Biological[MESH]|Neoplasms/*therapy[MESH]|Receptors, Lysophosphatidic Acid/physiology[MESH]|Receptors, Lysosphingolipid/physiology[MESH]|Sphingosine/analogs & derivatives/antagonists & inhibitors/physiology[MESH] |
